Mathew Maurer

Mathew S. Maurer, MD is a Professor of Medicine at Columbia University Irving Medical Center (CUIMC), Vagelos College of Physicians & Surgeons. He serves as Director of the Clinical Cardiovascular Research Laboratory for the Elderly (CCRLE) and the Cardiac Amyloidosis Program. His work bridges geriatrics and cardiovascular medicine, focusing on holistic approaches to improve functional capacity and quality of life in older adults with cardiovascular diseases.

• Education:
  • Medical School: Mount Sinai School of Medicine, CUNY
  • Internship, Residency, and Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center

Dr. Maurer specializes in heart failure, amyloidosis, and geriatric cardiology, with expertise in areas like heart failure with preserved ejection fraction (HFpEF) and hypertrophic cardiomyopathy. He has contributed to over 300 peer-reviewed publications, most notably co-chairing the ATTR-ACT trial on tafamidis therapy for transthyretin amyloid cardiomyopathy.

He is affiliated with NewYork-Presbyterian / Columbia University Irving Medical Center and holds board certifications in Advanced Heart Failure and Transplant Cardiology, Cardiovascular Disease, and Internal Medicine. His clinical practice includes Spanish language proficiency.